The synthesis of a series of novel trisubstituted pyrazole derivatives and their PIFA-mediated conversion to molecules bearing the fused pyrazolo[4,3-c]quinoline ring system is reported. The anti-angiogenic activity of these compounds was evaluated by using in vitro assays for endothelial cell proliferation and migration, and in the chicken chorioallantoic membrane (CAM) assay. Compounds containing the fused pyrazolo[4,3-c]quinoline motifs emerged as potent anti-angiogenic compounds, which also had the ability to inhibit the growth of human breast (MCF-7) and cervical (Hela) carcinoma cells in vitro. © 2010 Elsevier Ltd. All rights reserved.

Novel pyrazole derivatives: Synthesis and evaluation of anti-angiogenic activity / M.S. Christodoulou, S. Liekens, K.M. Kasiotis, S.A. Haroutounian. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 18:12(2010), pp. 4338-4350. [10.1016/j.bmc.2010.04.076]

Novel pyrazole derivatives: Synthesis and evaluation of anti-angiogenic activity

M.S. Christodoulou;
2010

Abstract

The synthesis of a series of novel trisubstituted pyrazole derivatives and their PIFA-mediated conversion to molecules bearing the fused pyrazolo[4,3-c]quinoline ring system is reported. The anti-angiogenic activity of these compounds was evaluated by using in vitro assays for endothelial cell proliferation and migration, and in the chicken chorioallantoic membrane (CAM) assay. Compounds containing the fused pyrazolo[4,3-c]quinoline motifs emerged as potent anti-angiogenic compounds, which also had the ability to inhibit the growth of human breast (MCF-7) and cervical (Hela) carcinoma cells in vitro. © 2010 Elsevier Ltd. All rights reserved.
Angiogenesis; CAM assay; Endothelial cell proliferation and migration; Inhibition of tumor growth; Pyrazole; Pyrazolo[4,3-c]quinoline; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Chickens; Chorioallantoic Membrane; Cytostatic Agents; Endothelial Cells; Humans; Mice; Pyrazoles; Quinolines; 3003; Drug Discovery3003 Pharmaceutical Science; Organic Chemistry; Molecular Medicine; Molecular Biology; Clinical Biochemistry; Biochemistry; Medicine (all)
Settore CHIM/06 - Chimica Organica
Settore CHIM/08 - Chimica Farmaceutica
2010
Article (author)
File in questo prodotto:
File Dimensione Formato  
Bioorganic & Medicinal Chemistry 18 (2010) 4338–4350.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 806.82 kB
Formato Adobe PDF
806.82 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/495953
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 122
  • ???jsp.display-item.citation.isi??? 112
social impact